Thrombocytagátlás acetilszalicilsavval Cardiovascularis indikációk és vérzéses szövó dmenyek

Translated title of the contribution: Antiplatelet therapy with acetylsalicylic acid - Cardiovascular indications and hemorrhagic complications

Research output: Contribution to journalArticle

Abstract

Acetylsalicylic acid effectively blocks the activation of platelets, and becomes a basic element of antithrombotic therapy of patients with high cardiovascular risk. Decrease of platelet reactivity is due to the irreversible inhibition of COX1 isoenzime in platelets during treatment. Choosing the right dose is still not an easy task. Bleeding side effects are frequently seen in patients treated with this drug worldwide. Clinical benefit does not improves with escalated doses (300 mg), however the risk of haemorrhagic events increases. Therefore acetylsalicylic acid dose should be reduced to the effective minimal dose (75-150 mg daily) after the acute phase of atherothrombosis in order to prevent side effects. Effect of acetylsalicylic acid differs individually, it might be important screening out those patients who respond less to the drug. Resistance is still an evolving field, proper methodology is to be determined. Right indications of acetylsalicylic acid needs balance between reaching clinical benefit and avoiding side effects. The Hungarian Cardiovascular Therapeutic Consensus Conference 2009 suggested acetylsalicylic acid in primary prevention for those males only, who have overt cardiovascular risk, and SCORE result is more than 10%, with no gastrointestinal haemorrhage in medical history, and with a well-controlled hypertension. Lifelong aspirin prevention should be used after all diagnosed cardiovascular atherothrombotic event as a cornerstone of secondary prevention with low dose (75-150 mg daily) in both genders.

Translated title of the contributionAntiplatelet therapy with acetylsalicylic acid - Cardiovascular indications and hemorrhagic complications
Original languageHungarian
Pages (from-to)125-130
Number of pages6
JournalLege Artis Medicinae
Volume20
Issue number2
Publication statusPublished - Feb 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Antiplatelet therapy with acetylsalicylic acid - Cardiovascular indications and hemorrhagic complications'. Together they form a unique fingerprint.

  • Cite this